NPs Basic Information

Name
2,3-Nonadiene
Molecular Formula C9H16
IUPAC Name*
NA
SMILES
CCCCCC=C=CC
InChI
InChI=1S/C9H16/c1-3-5-7-9-8-6-4-2/h3,7H,4,6,8-9H2,1-2H3
InChIKey
QPYQHAPIBCQICN-UHFFFAOYSA-N
Synonyms
2,3-Nonadiene; 22433-34-7; DTXSID60338477
CAS 22433-34-7
PubChem CID 549311
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Allenes
      • Class: Acyclic allenes
        • Subclass: No Rank at Level Subclass
          • Direct Parent: Acyclic allenes

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 124.22 ALogp: 3.3
HBD: 0 HBA: 0
Rotatable Bonds: 4 Lipinski's rule of five: Accepted
Polar Surface Area: 0.0 Aromatic Rings: 0
Heavy Atoms: 9 QED Weighted: 0.391

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.487 MDCK Permeability: 0.00001030
Pgp-inhibitor: 0.101 Pgp-substrate: 0.085
Human Intestinal Absorption (HIA): 0.003 20% Bioavailability (F20%): 0.005
30% Bioavailability (F30%): 0.068

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.979 Plasma Protein Binding (PPB): 89.53%
Volume Distribution (VD): 3.446 Fu: 15.42%

ADMET: Metabolism

CYP1A2-inhibitor: 0.484 CYP1A2-substrate: 0.717
CYP2C19-inhibitor: 0.034 CYP2C19-substrate: 0.908
CYP2C9-inhibitor: 0.032 CYP2C9-substrate: 0.67
CYP2D6-inhibitor: 0.002 CYP2D6-substrate: 0.048
CYP3A4-inhibitor: 0.034 CYP3A4-substrate: 0.212

ADMET: Excretion

Clearance (CL): 7.204 Half-life (T1/2): 0.702

ADMET: Toxicity

hERG Blockers: 0.042 Human Hepatotoxicity (H-HT): 0.505
Drug-inuced Liver Injury (DILI): 0.043 AMES Toxicity: 0.008
Rat Oral Acute Toxicity: 0.043 Maximum Recommended Daily Dose: 0.134
Skin Sensitization: 0.967 Carcinogencity: 0.597
Eye Corrosion: 0.992 Eye Irritation: 0.987
Respiratory Toxicity: 0.893
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001683 0.567 D01QLH 0.306
ENC001684 0.436 D0UE9X 0.224
ENC001597 0.429 D0O1TC 0.205
ENC001668 0.410 D0O1PH 0.197
ENC001598 0.395 D08SJZ 0.197
ENC000032 0.389 D0AY9Q 0.196
ENC001656 0.378 D0Y3KG 0.186
ENC001693 0.372 D0O3AB 0.182
ENC000139 0.367 D05ATI 0.180
ENC001600 0.366 D0N3NO 0.179
*Note: the compound similarity was calculated by RDKIT.